Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Sertraline and Chlorzoxazone Interaction Assessment

Mechanism of Potential Interaction

  • Sertraline, a selective serotonin reuptake inhibitor (SSRI), has minimal inhibitory effects on major cytochrome P450 enzymes, though it may interact with drugs metabolized by CYP2D6, according to the American Academy of Child and Adolescent Psychiatry 1

Safety Assessment

  • The American Geriatrics Society lists chlorzoxazone as a potentially inappropriate medication in older adults due to anticholinergic effects, but does not specifically contraindicate its use with sertraline, as stated in the 2019 Beers Criteria 2
  • Sertraline has been shown to have fewer drug-drug interactions compared to other SSRIs, such as fluvoxamine, which affects multiple CYP enzymes, as reported by the American Academy of Child and Adolescent Psychiatry 1

Monitoring Recommendations

  • Monitor for potential signs of increased chlorzoxazone effects, including enhanced sedation or drowsiness, dizziness or impaired coordination, and potential for increased anticholinergic effects, especially in older adults or those with hepatic impairment, as recommended by the American Academy of Child and Adolescent Psychiatry and the American Geriatrics Society 1, 2
  • If both medications are necessary, consider starting with lower doses of both medications and monitoring more frequently during the initial period of co-administration, especially in the first 24-48 hours, as suggested by the American Academy of Child and Adolescent Psychiatry 1

Clinical Perspective

  • When prescribing muscle relaxants with sertraline, consider alternatives to chlorzoxazone if there are concerns about potential interactions, as advised by the American Geriatrics Society 2
  • The benefit-to-risk ratio should be evaluated, particularly in older adults where chlorzoxazone is generally considered potentially inappropriate regardless of co-medications, according to the American Geriatrics Society 2